In a busy clinical practice setting, the simplest neuropsychological test to diagnose HIV dementia is? a. Standard Mini-Mental Status test b. HIV-dementia scale c. Memorial Sloan Kettering Scale d. Halstead-Reitan Neuropsychological Battery e. San Diego HIV Neurobehavioral Research Center

Short Answer

Expert verified
Answer: b. HIV-dementia scale

Step by step solution

01

Understanding the terms

It's important to understand what each option refers to in terms of neuropsychological tests. Understand the purpose and complexity of each test: a. Standard Mini-Mental Status test: This test is a quick cognitive assessment tool that screens for cognitive impairment. It is brief and easy to administer but not specific to HIV dementia. b. HIV-dementia scale: This scale is designed to screen specifically for HIV-associated neurocognitive disorders, including HIV dementia. c. Memorial Sloan Kettering Scale: This scale is used primarily to assess cognitive dysfunction in cancer patients, not for HIV dementia. d. Halstead-Reitan Neuropsychological Battery: This comprehensive battery of tests measures cognitive and neuropsychological functioning but takes much longer to administer. e. San Diego HIV Neurobehavioral Research Center: This is not a test but rather a research center for studying HIV neurobehavioral disorders.
02

Evaluating the best option

Now that we understand the purpose and complexity of each test, we can determine which one is the simplest and most appropriate for diagnosing HIV dementia in a busy clinical practice setting. Since the question asks for the simplest test, we can focus on the specific purposes and lengths of each test to decide which one fits the criteria best.
03

Choose the best option

Based on the information given in Step 2, the HIV-dementia scale is the most appropriate choice for diagnosing HIV dementia in a busy clinical practice setting. It is specifically designed for HIV-associated neurocognitive disorders, and it is also a quick and simple test. Therefore, the answer is: b. HIV-dementia scale

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with Vaia!

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

Nucleoside analogue reverse transcriptase inhibitors are drugs of diverse chemical structure that act by non-competitive inhibition of HIV-1 reverse transcriptase. True/False

What is correct about the "Trojan Horse" model of HIV invasion into the CNS? a. Proposes that monocyte-macrophage carry progeny virions from blood to the brain inside cytoplasmic vacuoles and across the blood-brain barrier b. Requires an inflammatory response in the brain, which elicits a chemokine gradient c. After infiltrating the brain parenchyma, blood borne monocyte-macrophages also release additional chemokines and further attract additional inflammatory cells d. Does not require productive viral replication in brain microvascular endothelial cells e. All of the above

Which of the following nucleoside reverse transcriptase inhibitors has the best penetration into CSF? a. Zidovudine b. Didanosine c. Lamivudine d. Stavudine e. Abacavir

Contemporary treatment of HIV infection requires the use of two nucleoside reverse transcriptase inhibitors (NRTI) combined with either a non-nucleoside reverse transcriptase inhibitors or a protease inhibitor. Which of the following NRTI backbones will you prefer to use in a patient recently diagnosed with HIV-associated dementia: a. Zidovudine plus stavudine b. Zidovudine plus lamivudine c. Zalcitabine plus didanosine d. Zalcitabine plus lamivudine e. Didanosine plus tenofovir

Currently there are six classes of antiretroviral agents available in the United States for clinical use: \- Nucleoside analogue reverse transcriptase inhibitors \- Nonnucleoside analogue reverse transcriptase inhibitors \- Protease inhibitors \- Entry inhibitors \- Tat inhibitors \- Nef inhibitors True/False

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free